Voloridge Investment Management LLC lowered its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 64.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 90,971 shares of the company's stock after selling 167,060 shares during the period. Voloridge Investment Management LLC owned approximately 0.20% of Azenta worth $4,549,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. KLP Kapitalforvaltning AS purchased a new position in shares of Azenta in the 4th quarter worth approximately $530,000. State of Alaska Department of Revenue lifted its stake in Azenta by 355.2% in the fourth quarter. State of Alaska Department of Revenue now owns 25,899 shares of the company's stock valued at $1,294,000 after purchasing an additional 20,210 shares during the last quarter. Stephens Inc. AR purchased a new position in Azenta in the fourth quarter valued at approximately $313,000. Thrivent Financial for Lutherans lifted its stake in Azenta by 206.5% in the fourth quarter. Thrivent Financial for Lutherans now owns 35,223 shares of the company's stock valued at $1,761,000 after purchasing an additional 23,731 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new position in Azenta in the fourth quarter valued at approximately $813,000. Hedge funds and other institutional investors own 99.08% of the company's stock.
Azenta Stock Performance
AZTA stock traded down $0.61 during midday trading on Friday, reaching $26.72. 715,882 shares of the company's stock traded hands, compared to its average volume of 696,038. The firm has a market capitalization of $1.22 billion, a PE ratio of -8.97 and a beta of 1.64. Azenta, Inc. has a 52 week low of $23.91 and a 52 week high of $63.58. The company has a 50-day moving average price of $28.02 and a two-hundred day moving average price of $40.34.
Azenta (NASDAQ:AZTA - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Azenta's quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.06 earnings per share. As a group, analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the company. TD Cowen upgraded Azenta to a "hold" rating in a research note on Thursday, February 27th. Evercore ISI boosted their target price on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, Needham & Company LLC lowered their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th.
View Our Latest Research Report on Azenta
Azenta Profile
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Stories

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.